Friday, December 09, 2005
Cephalon Inc. and Teva Pharmaceutical Industries said Dec. 9, 2005 that they have agreed to settle a patent dispute over the fatigue treatment Provigil.
Intellectual property news affecting business and everyday life
0 Comments:
Post a Comment
<< Home